{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T04:23:36Z","timestamp":1785644616611,"version":"3.56.0"},"reference-count":48,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DDDT"],"DOI":"10.2147\/dddt.s253064","type":"journal-article","created":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T23:02:10Z","timestamp":1591830130000},"page":"2307-2317","source":"Crossref","is-referenced-by-count":23,"title":["<p>Scalable in silico Simulation of Transdermal Drug Permeability: Application of BIOiSIM Platform<\/p>"],"prefix":"10.2147","volume":"Volume 14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7512-1737","authenticated-orcid":true,"given":"Neha","family":"Maharao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Antontsev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hypatia","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1608-0207","authenticated-orcid":true,"given":"Jyotika","family":"Varshney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2020,6]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1038\/nbt.1504","volume":"26","author":"Prausnitz","year":"2008","journal-title":"Nat Biotechnol"},{"key":"ref2","unstructured":"Zion Market Research. Global transdermal drug delivery system market will reach USD 8,127 Million By 2025: zion Market Research. Available from: https:\/\/www.globenewswire.com\/news-release\/2019\/09\/05\/1911711\/0\/en\/Global-Transdermal-Drug-Delivery-System-Market-Will-Reach-USD-8-127-Million-By-2025-Zion-Market-Research.html. Accessed February 14, 2020."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1080\/10717540500455975","volume":"13","author":"Brown","year":"2006","journal-title":"Drug Deliv"},{"key":"ref4","volume-title":"Principles of Anatomy and Physiology","year":"2018"},{"key":"ref5","volume-title":"Dermal and Transdermal Formulations: How They Can Affect the Active Compound","year":"2015"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1017\/S1867299X00005158","volume":"6","author":"Fischer","year":"2015","journal-title":"Eur J Risk Regul"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3390\/pharmaceutics9030033","volume":"9","author":"Todo","year":"2017","journal-title":"Pharmaceutics"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1002\/jps.23155","volume":"101","author":"Polak","year":"2012","journal-title":"J Pharm Sci"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1080\/1062936X.2018.1518928","volume":"29","author":"Zhang","year":"2018","journal-title":"SAR QSAR Environ Res"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/S0169-409X(03)00118-2","volume":"55","author":"Yamashita","year":"2003","journal-title":"Adv Drug Deliv Rev"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1007\/s11095-016-1900-x","volume":"33","author":"Chen","year":"2016","journal-title":"Pharm Res"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/03602532.2020.1726944","author":"Maharao","year":"2020","journal-title":"Drug Metab Rev"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1002\/psp4.12134","volume":"5","author":"Kuepfer","year":"2016","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"ref14","unstructured":"Integrated Physiology Database. PK-Sim\u00ae, Bayer Technology Services GmbH, Leverkusen, Germany. Available from: http:\/\/www.systems-biology.com\/products\/pk-sim.html. Accessed May 12, 2020."},{"key":"ref15","unstructured":"US Environmental Protection Agency Office of Health and Environmental Assessment. Physiological Parameter Values for PBPK Models: A Report Prepared by the International Life Sciences Institute and Risk Sciences Institute; 1994."},{"key":"ref16","unstructured":"ICRP. Basic anatomical and physiological data for use in radiological protection reference values. Ann ICRP. 2002;32:3\u20134."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1177\/074823379701300401","volume":"13","author":"Brown","year":"1997","journal-title":"Toxicol Ind Health"},{"key":"ref18","volume-title":"Physiologically\u2010Based Pharmacokinetic (PBPK) Modeling and Simulations: Principles, Methods, and Applications in the Pharmaceutical Industry","year":"2012"},{"key":"ref19","unstructured":"Drug bank \u2013 Morphine. Available from: https:\/\/www.drugbank.ca\/drugs\/DB00295. Accessed February 14, 2020."},{"key":"ref20","unstructured":"Drug bank \u2013 Buprenorphine. Available from: https:\/\/www.drugbank.ca\/drugs\/DB00921. Accessed February 14, 2020."},{"key":"ref21","unstructured":"Drug bank - Nicotine Available from: https:\/\/www.drugbank.ca\/drugs\/DB00184. Accessed February 14, 2020.."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.1111\/bcp.13368","volume":"83","author":"Kalluri","year":"2017","journal-title":"Br J Clin Pharmacol"},{"key":"ref23","unstructured":"Food and Drug Administration (FDA). Prescribing information - BUTRANS (June 2014). Accessed February 14, 2020."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.drugalcdep.2012.11.014","volume":"131","author":"Huestis","year":"2013","journal-title":"Drug Alcohol Depend"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/BF01064421","volume":"20","author":"Robinson","year":"1992","journal-title":"J Pharmacokinet Biopharm"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/clpt.1991.138","volume":"50","author":"Benowitz","year":"1991","journal-title":"Clin Pharmacol Ther"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/978-3-540-69248-5_2","volume":"192","author":"Benowitz","year":"2009","journal-title":"Handb Exp Pharmacol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/j.1365-2125.1985.tb02637.x","volume":"19","author":"Feyerabend","year":"1985","journal-title":"Br J Clin Pharmacol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/jat\/22.4.261","volume":"22","author":"Skopp","year":"1998","journal-title":"J Anal Toxicol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1111\/j.1365-2125.1994.tb04306.x","volume":"37","author":"Westerling","year":"1994","journal-title":"Br J Clin Pharmacol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.3109\/03639049309069337","volume":"19","author":"Lane","year":"1993","journal-title":"Drug Dev Ind Pharm"},{"key":"ref32","volume-title":"Transdermal Drug Delivery Systems: Revised and Expanded","year":"2002"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1208\/s12249-019-1481-1","volume":"20","author":"Iikura","year":"2019","journal-title":"AAPS PharmSciTech"},{"key":"ref34","unstructured":"Rohatgi A. WebPlotDigitizer; 2019. Available from: https:\/\/automeris.io\/WebPlotDigitizer. Accessed May 12, 2020."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.jpainsymman.2007.04.016","volume":"35","author":"Paice","year":"2008","journal-title":"J Pain Symptom Manage"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jpainsymman.2012.06.014","volume":"46","author":"Kapil","year":"2013","journal-title":"J Pain Symptom Manage"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"661","DOI":"10.2165\/00003088-200544070-00001","volume":"44","author":"Elkader","year":"2005","journal-title":"Clin Pharmacokinet"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1093\/jat\/20.6.369","volume":"20","author":"Kuhlman","year":"1996","journal-title":"J Anal Toxicol"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1002\/bdd.2050","volume":"38","author":"Maharao","year":"2017","journal-title":"Biopharm Drug Dispos"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1002\/bdd.2166","volume":"40","author":"Maharao","year":"2019","journal-title":"Biopharm Drug Dispos"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"146","DOI":"10.5114\/aoms.2018.72566","volume":"15","author":"Cia\u0142kowska-Rysz","year":"2019","journal-title":"Arch Med Sci"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.jpainsymman.2008.06.007","volume":"37","author":"LeBon","year":"2009","journal-title":"J Pain Symptom Manage"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"2542","DOI":"10.1200\/JCO.2001.19.9.2542","volume":"19","author":"Cherny","year":"2001","journal-title":"J Clin Oncol"},{"key":"ref44","first-page":"39","volume":"19","author":"Wilken","year":"2005","journal-title":"J Pain Palliat Care Pharmacother"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"41","DOI":"10.2165\/0044011-200929001-00006","volume":"29 Suppl 1","author":"Marchi","year":"2009","journal-title":"Clin Drug Investig"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1182\/blood-2018-99-115084","volume":"132","author":"Albo","year":"2018","journal-title":"Blood"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s12974-019-1608-z","volume":"16","author":"Cao","year":"2019","journal-title":"J Neuroinflammation"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1124\/dmd.118.082966","volume":"46","author":"Lombardo","year":"2018","journal-title":"Drug Metab Dispos"}],"container-title":["Drug Design, Development and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=58806","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=58806","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T23:02:18Z","timestamp":1591830138000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/scalable-in-silico-simulation-of-transdermal-drug-permeability-applica-peer-reviewed-article-DDDT"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":48,"URL":"https:\/\/doi.org\/10.2147\/dddt.s253064","relation":{},"ISSN":["1177-8881"],"issn-type":[{"value":"1177-8881","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6]]}}}